← Back to Search

Device

Accuryn Monitoring System for Acute Kidney Injury

N/A
Recruiting
Research Sponsored by Potrero Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Summary

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.

Eligible Conditions
  • Acute Kidney Injury
  • Cardiac Surgery
  • Abdominal Compartment Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Abdominal Compartment Syndrome (ACS)
Kidney
Intra-Abdominal Pressure (IAP)
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Accuryn Monitoring SystemExperimental Treatment1 Intervention
Observational only (no intervention). Patients undergoing cardiovascular surgical intervention(s) monitored with the Accuryn Monitoring System (per standard of care) during their hospital stay
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Accuryn Monitoring System
2017
N/A
~50

Find a Location

Who is running the clinical trial?

Potrero MedicalLead Sponsor
7 Previous Clinical Trials
183 Total Patients Enrolled
3 Trials studying Acute Kidney Injury
62 Patients Enrolled for Acute Kidney Injury
Vanessa Moll, MD, PhDStudy DirectorPotrero Medical
~937 spots leftby Dec 2026